CIBC Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

CIBC Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,230	Closed	-$1.51M	–	978
2016 Q2	$1.51M	Hold	14,230	–	–	0.01%	443
2016 Q1	$1.63M	Buy	14,230 +3,690	+35%	+$433K	0.01%	416
2015 Q4	$1.5M	Buy	10,540 +3,080	+41%	+$356K	0.01%	431
2015 Q3	$670K	Sell	7,460 -55,550	-88%	-$5.86M	0.01%	610
2015 Q2	$7.26M	Buy	+63,010	New	+$6.62M	0.05%	154

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIBC Asset Management's CBPO Position: Q3 2016 in Review

CIBC Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2016, closing a stake of 14,230 shares — an estimated $1.51M sold.

CIBC Asset Management first reported a position in CBPO in Q2 2015 and held it in 5 quarters. The position peaked at $7.26M in Q2 2015. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

CIBC Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
CIBC Asset Management sold 14,230 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $1.51M.
CIBC Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 5 quarters.
CIBC Asset Management's China Biologic Products Holdings, Inc. position peaked at $7.26M in Q2 2015.
162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on CIBC Asset Management's 13F filing for Q3 2016, filed 19 Oct 2016.